Stay updated on Ivosidenib and Chemo Combo for IDH1-Mutant AML Clinical Trial
Sign up to get notified when there's something new on the Ivosidenib and Chemo Combo for IDH1-Mutant AML Clinical Trial page.

Latest updates to the Ivosidenib and Chemo Combo for IDH1-Mutant AML Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check17 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check59 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check67 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 13, 2025. However, the deletion of the date March 25, 2025, does not significantly impact the core content.SummaryDifference1.0%
- Check110 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
Stay in the know with updates to Ivosidenib and Chemo Combo for IDH1-Mutant AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ivosidenib and Chemo Combo for IDH1-Mutant AML Clinical Trial page.